FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely cardiology, and concerns sinus rhythm restoration in atrial flutter type 1. That is ensured by atrial or transesophageal pacing. Arrhythmia preserved after the pacing required the intravenous introduction of amiodarone 150 mg during 5-7 minutes and another atrial or transesophageal pacing in 10-15 minutes.
EFFECT: empirically selected dose and dose schedule of amiodarone provides effective sinus rhythm restoration by increasing sensitivity of the conducting system of heart to electric pulse exposure with no side effects.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCTION OF REGULAR FORM OF AURICULAR FLUTTERING | 2008 |
|
RU2381006C1 |
| METHOD FOR PREDICTING RELAPSES OF FIRSTLY APPEARED PAROXYSMS OF ATRIAL FIBRILLATION | 1999 |
|
RU2192775C2 |
| METHOD FOR TREATING ATRIAL FLUTTER PAROXYSM PATIENTS | 2000 |
|
RU2189262C2 |
| METHOD FOR PREDICTING ATRIAL FIBRILLATION AND FLUTTER | 2000 |
|
RU2181257C1 |
| METHOD FOR SELECTING ANTIRECIDIVATION THERAPY OF THE FIBRILLATION PAROXYSMS AND ATRIAL FLUTTER ARISEN FOR THE FIRST TIME | 1999 |
|
RU2192776C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF PAROXYSMS OF ATRIAL FLUTTER AND FIBRILLATION IN PATIENTS AT SUPRAVENTRICULAR EXTRASYSTOLIA | 2005 |
|
RU2294137C2 |
| METHOD FOR PREDICTING PAROXYSMS OF AURICULAR FIBRILLATION | 2000 |
|
RU2195872C2 |
| METHOD FOR PREVENTING ATRIAL FIBRILLATION AND FLUTTER PAROXYSMS | 2002 |
|
RU2219975C2 |
| METHOD FOR PREVENTING FLUTTER AND FIBRILLATION PAROXYSMS DEVELOPMENT IN ATRIA BEING REFRACTORY TO PHARMACEUTICAL ANTIARRHYTHMIA THERAPY | 2004 |
|
RU2268079C1 |
| METHOD FOR BLOCKING ATRIAL FLUTTER | 0 |
|
SU1683678A1 |
